Antibody Detection – Nursing Home Residents

Angie Szumlinski Studies

In a recent study, medical experts from several universities and the Veterans Administration found that vulnerable older adults can mount an antibody response to SARS-CoV-2 and that antibodies are most likely to be detected within 15-30 days of diagnosis. That antibodies were detected in a large proportion of residents with no confirmed SARS-CoV-2 infection highlights the complexity of identifying who …

One or Two Doses?

Angie Szumlinski Health, Studies

Arguments have been made that because COVID-19 is such a serious disease that is rapidly spreading throughout the world and because vaccines can be made and delivered at a relatively slow rate, a first dose should be given and the second dose delayed until a large amount of the population receives the first dose. To be clear, it is known …

Frailty and Comorbidities – COVID-19 Outcomes

Angie Szumlinski Health, Studies

A study conducted in Sweden during the COVID-19 pandemic had some very interesting variables and outcomes. The study was performed in an acute care setting with geriatric patients with the goal of analyzing whether frailty and comorbidities are associated with in-hospital mortality and discharge to home. The COVID-19 diagnosis was clinically confirmed by positive reverse transcription-polymerase chain reaction test, or, …

Toothbrush Disinfection – Protect Against COVID-19

Angie Szumlinski Health, Studies

Brazilian researchers have found that toothbrushes can act as reservoirs for microorganisms and favor the transmission of diseases such as COVID-19. Patients who are infected with SARS-CoV-2 have “high viral loads in saliva, nasopharynx and oropharynx” which can occur even in asymptomatic people. A recent study demonstrated that commercially available mouthwashes can inactivate SARS-CoV-2 in vitro. The results showed that …

Reopening Schools – JAMA Viewpoint

Angie Szumlinski Studies

On March 11, 2020, less than two weeks after community transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified in the U.S., the World Health Organization declared that the novel coronavirus (COVID-19) outbreak was a global pandemic. By March 25, 2020, all kindergarten to grade 12 (K-12) public schools in the U.S. had closed for in-person instruction. …

Saliva Nucleic Acid Testing (NAAT)

Angie Szumlinski Studies

Testing is the cornerstone of a successful public health response to coronavirus disease 2019 (COVID-19). Nasopharyngeal swab nucleic acid amplification testing (NAAT) is the non-invasive criterion standard for diagnosis of coronavirus disease 2019 (COVID-19). However, it requires trained personnel, limiting its availability, and the technique cannot be easily or reliably performed in all populations (i.e., children and quarantined individuals).  Consequently, …

CDC Updates

Angie Szumlinski Announcements, Featured

The CDC has updated the Guidance on Testing Healthcare Personnel for SARS CoV-2: Criteria for Return to Work for Healthcare Personnel with Confirmed or Suspected COVID-19 (Interim Guidance) – February 14, 2021 CDC Science Agenda for COVID-19 – February 15, 2021 Interim Guidance on Testing Healthcare Personnel for SARS-CoV-2 – February 14, 2021 U.S. COVID-19 Cases Caused by Variants – …

The Debate – One or Two Doses

Angie Szumlinski Health, Studies

Health experts have conditionally backed the U.K.’s decision to delay administering a second dose of the coronavirus vaccine developed by Pfizer and BioNTech, warning that the need to suppress the new coronavirus strain “cannot be overstated.”  On December 30, 2020, following MHRA approval of the Oxford AstraZeneca vaccine, the four UK Chief Medical Officers, based on a recommendation by the …

Israel Sees 60% Drop in Hospitalizations

Angie Szumlinski News, Studies

The full effects of Pfizer’s vaccine are only slated to kick in around a month after the first shot, but data from Israel, home to the world’s fastest vaccination drive, has already shown that there is a stark drop in infections even before this point. Drawing widespread, international interest by sharing early data, Maccabi Healthcare Services reported earlier this month …

Pfizer First Dose – Allergic Reactions

Angie Szumlinski Studies

On December 11, 2020, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine, administered as two doses separated by 21 days. Notifications and reports of suspected severe allergic reactions and anaphylaxis following vaccination were captured in the Vaccine Adverse Event Reporting System (VAERS), the national passive surveillance (spontaneous …